BioSpace News Archive

Akoya Biosciences, Inc., The Spatial Biology Company®, announced the launch of PhenoCode™ Signature Panels for high-throughput spatial biomarker discovery and validation on the PhenoImager® platforms.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended September 30, 2022 and provided a corporate update.

Curis, Inc. announced that the Company along with its collaborative partners will be presenting three posters at the upcoming 37th Annual Meeting of the Society for Immunotherapy of Cancer being held in Boston, MA and virtually from November 8th to November 12th.

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that on November 2, 2022, TransMedics granted non-qualified stock options to purchase an aggregate of 138,400 shares of its common stock to six employees as a material inducement for each employee’s entry into employment with TransMedics.

bluebird bio, Inc. today reported financial results and business highlights for the third quarter ended September 30, 2022 and shared recent operational progress.

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to advance its mission of providing powerful, industry-leading methods of cellular analysis.

Cerevance today announced a poster presentation at the Society for Neuroscience (SFN) 2022 conference, to be held in San Diego, California and virtually on November 12-16, 2022.

Immunovant, Inc. today announced that Pete Salzmann, M.D., chief executive officer, will participate in a fireside chat at the Guggenheim 4th Annual Immunology and Neurology Day, taking place November 14th -15th , 2022.

Oryzon Genomics, S.A has been selected for oral presentation at the upcoming 64th American Society of Hematology (ASH) Annual Meeting and Exposition, to be held December 10-13, 2022 in New Orleans.

TransCode Therapeutics, Inc. today announced that it will be presenting at the Sidoti Virtual Conference.